At the 2025 ASCO Gastrointestinal Cancers Symposium, Auristone presented its first poster at the GI-focused meeting, titled “Transcriptomic features of Epstein-Barr virus-associated gastric cancer based on PD-L1 status.”

Conducted in collaboration with Professor Sun Young Rha, this study highlights the transcriptomic distinctions within Epstein-Barr virus-associated gastric cancer (EBVaGC), stratified by PD-L1 expression. The findings provide new insights into the molecular landscape of EBVaGC and its potential relevance to immunotherapy response.

This milestone reflects Auristone’s ongoing commitment to advancing epigenomic and transcriptomic research through meaningful clinical partnerships and a focus on cancers with high unmet needs.